Cargando…

Assessment of quality of life in patients with post kalaazar dermal leishmaniasis

BACKGROUND: Post kala-azar dermal leishmaniasis (PKDL) is a dermatological disorder caused by protozoal parasite Leishmania donovani. PKDL cases are thought to be a reservoir of parasites and may increase cases of visceral leishmaniasis. The disease is not life threatening but cosmetic disfigurement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pal, Biplab, Murti, Krishna, Siddiqui, Niyamat Ali, Das, Pradeep, Lal, Chandra Shekhar, Babu, Rajendra, Rastogi, Manoj Kumar, Pandey, Krishna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525288/ https://www.ncbi.nlm.nih.gov/pubmed/28738881 http://dx.doi.org/10.1186/s12955-017-0720-y

Ejemplares similares

Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India
por: Garapati, Pavan, et al.
Publicado: (2018)

To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)
por: Rabi Das, Vidya Nand, et al.
Publicado: (2017)

Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
por: Pandey, Krishna, et al.
Publicado: (2020)

Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis
por: Veeri, Rajendra Babu, et al.
Publicado: (2019)

Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study
por: Verma, Neena, et al.
Publicado: (2015)

Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers
por: Das, Vidya Nand Rabi, et al.
Publicado: (2020)

Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study
por: Das, Sushmita, et al.
Publicado: (2016)

Microalbuminuria and Glomerular Filtration Rate in Paediatric Visceral Leishmaniasis
por: Verma, Neena, et al.
Publicado: (2013)

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2016)

Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients
por: SINGH, Ashish Kumar, et al.
Publicado: (2018)

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2020)

Advanced case of PKDL due to delayed treatment: A rare case report
por: Topno, Roshan Kamal, et al.
Publicado: (2020)

Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal
por: Joshi, Anand Ballabh, et al.
Publicado: (2023)

Post Kala-azar Dermal Leishmaniasis
por: Das, Nilay Kanti
Publicado: (2020)

Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysis
por: Kumar, Vijay, et al.
Publicado: (2022)

Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India
por: J. S., Devipriya, et al.
Publicado: (2021)

Tuberous sclerosis with visceral leishmaniasis: a case report
por: Pandey, Krishna, et al.
Publicado: (2009)

Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients
por: Vijayamahantesh,, et al.
Publicado: (2016)

A Case of Post-Kala-Azar Dermal Leishmaniasis
por: Dey, Nepal Chandra
Publicado: (1929)

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2009)

Epidemiology of Post-Kala-azar Dermal Leishmaniasis
por: Ghosh, Pramit, et al.
Publicado: (2021)

Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
por: Sundar, Shyam, et al.
Publicado: (2014)

Further Clinical Observations on Post-Kala-Azar Dermal Leishmaniasis
por: Napier, L. Everard, et al.
Publicado: (1934)

A Clinical Study of Post-Kala-Azar Dermal Leishmaniasis
por: Napier, L. Everard, et al.
Publicado: (1930)

Atypical Post Kala Azar Dermal Leishmaniasis with “Muzzle Area” Swelling
por: Arora, Sandeep, et al.
Publicado: (2015)

Easy Test for Visceral Leishmaniasis and Post–Kala-azar Dermal Leishmaniasis
por: Saha, Samiran, et al.
Publicado: (2011)

The Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Napier, L. Everard, et al.
Publicado: (1930)

Extensive Post-Kala-Azar Dermal Leishmaniasis
por: Dev, Tanvi, et al.
Publicado: (2018)

Dermoscopy of Post Kala-Azar Dermal Leishmaniasis
por: Jha, Abhijeet K., et al.
Publicado: (2018)

Biomarkers in Post-kala-azar Dermal Leishmaniasis
por: Zijlstra, Eduard E.
Publicado: (2019)

Histopathology of Post Kala-azar Dermal Leishmaniasis
por: Ramesh, V, et al.
Publicado: (2020)

Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis
por: Kumar, Piyush, et al.
Publicado: (2021)

HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report
por: Pandey, Krishna, et al.
Publicado: (2008)

Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2021)

A case of miltefosine responsive pleomorphic post kala-azar dermal leishmaniasis
por: Pal, Dipankar, et al.
Publicado: (2013)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India
por: Boettcher, Jan P, et al.
Publicado: (2015)

Post-kala-azar Dermal Leishmaniasis Developing in Miltefosine-Treated Visceral Leishmaniasis
por: Koley, Sankha, et al.
Publicado: (2013)

Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission
por: Le Rutte, Epke A., et al.
Publicado: (2019)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u2oo653pn9qh3m051gbg25d5pu